APA Alıntı

Vardi, M., & Levy, A. P. (2012). Is it time to screen for the Haptoglobin genotype to assess the cardiovascular risk profile and vitamin E therapy responsiveness in patients with diabetes?

Chicago Stili Alıntı

Vardi, Moshe, ve Andrew P. Levy. Is It Time to Screen for the Haptoglobin Genotype to Assess the Cardiovascular Risk Profile and Vitamin E Therapy Responsiveness in Patients With Diabetes? 2012.

MLA Alıntı

Vardi, Moshe, ve Andrew P. Levy. Is It Time to Screen for the Haptoglobin Genotype to Assess the Cardiovascular Risk Profile and Vitamin E Therapy Responsiveness in Patients With Diabetes? 2012.